Skip to content
Kalpvruksh Markets
Offline Log in

POLYMEDNSEOffline

POLY MEDICURE · INE205C01021 · Small Cap · #432
1,602.20+15.40 (+0.97%)last close · 05 Nov 2026
Prev close
1,586.80
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹14,888 cr
52-week range · to 05 Nov 20261,191.12,063.4

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

POLYMED is 22% below its 52-week high, above its 200-day average, behind Healthcare by 7.1 pts over 3 months — a Small Cap company, #432 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 22% below its 52-week high
  • behind its industry by 7.1 pts over 3 months · rank 36 of 44 in Healthcare · −4.2% vs Nifty 500
  • traded value 1.1× usual · delivery 45% vs 48% usual
  • FPI −0.2 pp · DII −0.2 pp · MF schemes in Sept 2026: 17 bought, 36 cut · no promoter pledge · quarter ended 2026-09-30
  • Jun 2026 quarter: profit −8% year on year · revenue +30%
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹14,888 cr
Rank
#432
Cap band
Small Cap
Nearest cut-off — Mid / Small
−56.46% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.9×
median 40,574
Delivered
75,463
Of volume
24%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+9.6%+3.5 pts—
1 month−1.9%−6.2 pts−5.6 pts
3 months−6.2%−4.2 pts−7.1 pts
6 months−3.2%−3.6 pts−12.7 pts
1 year−18.8%−16.7 pts—

Industry: Healthcare (Nifty 500 classification) · rank 36 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+4.8%
above
vs 50-day average
−2.0%
below
vs 200-day average
+3.6%
above
ATR (14)
4.1%
typical daily range
Volatility
37%
1 month, annualised
Beta
1.01
vs Nifty 500, 1 year
Traded value
1.1×
vs usual
Delivery
45%
usual 48%
From the 52-week high
−22.4%
place in range 47% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters62.4%62.4%62.4%62.4%
FPI9.4%5.9% −3.55.6% −0.45.4% −0.2
Mutual funds8.1%8.8% +0.79.6% +0.89.8% +0.2
Other DII5.7%6.8% +1.16.5% −0.36.1% −0.3
Individuals11.3%12.6% +1.312.2% −0.412.3% +0.1
Others3.0%3.5% +0.43.8% +0.34.0% +0.3

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
74,153
Individuals
70,830

Indian passive funds’ stake

2026-06-30

Of free float
0.77%
Of all shares
0.29%
Schemes
49
Days to unwind
2.8
at 100% of volume

2,93,771 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
74
49 index · 25 active
Bought more
36
Sold some
13
FundSharesChangeDid
Bandhan Small Cap Fund-Reg(G)Active+51,057+87.3%bought
ITI Pharma & Healthcare Fund-Reg(G)Active+6,992+58.1%bought
WOC Pharma and Healthcare Fund-Reg(G)Active+11,445+34.9%bought
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETFIndex−5,485−18.9%sold
DSP Nifty Smallcap250 Quality 50 Index Fund-Reg(G)Index−480−1.6%sold
HDFC NIFTY Smallcap 250 ETFIndex−354−0.8%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2669314324−1.3%₹1,652 cr
Aug 267043771+3.4%₹1,759 cr
Jul 266733083+1.2%₹1,645 cr
Jun 2667527141+8.6%₹1,612 cr
May 2663119171−0.4%₹1,188 cr
Apr 266313090+0.0%₹1,335 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Poly Medicure Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    05 Nov 2026
  • Board outcome
    Poly Medicure Limited has informed the outcome of Board Meeting held on today i.e. 07th August, 2026 and submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
    07 Aug 2026
  • Credit rating
    Poly Medicure Limited has informed the Exchange about Credit Rating- Outlook Revision and Rating Re-affirmed
    29 Jun 2026
  • Takeover (SAST)
    Poly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
    10 Jun 2026
  • Takeover (SAST)
    Poly Medicure Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
    09 Jun 2026
  • Board outcome
    Outcome of Board Meeting-XBRL POLY MEDICURE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 25-May-2026 for Dividend
    27 May 2026

Latest shown; 7 in six months on all disclosures.

POLYMED: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
RecentDividend₹3.5Final28 Aug 202629 Aug 2026
EarlierDividend₹3.5Final18 Sept 202518 Sept 2025
EarlierDividend₹3Final19 Sept 202420 Sept 2024
EarlierDividend₹3Final21 Sept 202322 Sept 2023
EarlierDividend₹2.5Final16 Sept 202220 Sept 2022
EarlierDividend₹2.5Final16 Sept 202118 Sept 2021
EarlierBonus1:1—24 Mar 201728 Mar 2017
EarlierBonus1:1—09 Jul 201310 Jul 2013
EarlierBonus1:1—26 Mar 201029 Mar 2010

9 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.